HashClone: a new tool to quantify the minimal residual disease in B-cell lymphoma from deep sequencing data.
Marco BeccutiElisa GenuardiGreta RomanoLuigia MonitilloDaniela BarberoMario BoccadoroMarco LadettoRaffaele CalogeroSimone FerreroFrancesca CorderoPublished in: BMC bioinformatics (2017)
Our experiments show that in all the experimental settings, HashClone was able to correctly detect the major B-cell clones and to precisely follow them in several samples showing better accuracy than the state-of-art tool.